The company has jointly established the "Cross-Strait Joint Research Institute" with Taiwan's Chung-Hwa Research Institute to integrate scientific research resources on both sides of the strait, focus on cutting-edge technologies, and create a new drug research and development center for multiple dosage forms. Through in-depth cooperation, we will continue to expand the boundaries of technology and promote the development and industrialization of innovative drugs.